IFNG and neoplasm: In fact, by artificially mixing IFN-γ-sensitive and IFN-γ-resistant tumors, we observed outgrowth of resistant cells upon CAR4 T-cell therapy, possibly reflecting the emergence of tumor cells with mutations in the IFN-γ pathway observed in preclinical models53,54 or in patients treated by immunotherapy55.